Glaukos Return on Tangible Equity 2014-2025 | GKOS
Current and historical return on tangible equity values for Glaukos (GKOS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Glaukos Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.12B | $0.44B | -32.35% |
| 2024-12-31 | $-0.15B | $0.44B | -49.16% |
| 2024-09-30 | $-0.15B | $0.33B | -68.81% |
| 2024-06-30 | $-0.16B | $0.32B | -96.22% |
| 2024-03-31 | $-0.14B | $0.10B | -121.29% |
| 2023-12-31 | $-0.14B | $0.11B | -107.36% |
| 2023-09-30 | $-0.13B | $0.12B | -94.51% |
| 2023-06-30 | $-0.13B | $0.13B | -85.81% |
| 2023-03-31 | $-0.14B | $0.14B | -87.36% |
| 2022-12-31 | $-0.10B | $0.16B | -56.74% |
| 2022-09-30 | $-0.09B | $0.17B | -49.39% |
| 2022-06-30 | $-0.06B | $0.18B | -29.80% |
| 2022-03-31 | $-0.03B | $0.21B | -14.70% |
| 2021-12-31 | $-0.05B | $0.19B | -26.89% |
| 2021-09-30 | $-0.04B | $0.20B | -19.36% |
| 2021-06-30 | $-0.06B | $0.17B | -29.23% |
| 2021-03-31 | $-0.08B | $0.17B | -37.99% |
| 2020-12-31 | $-0.12B | $0.24B | -53.72% |
| 2020-09-30 | $-0.07B | $0.23B | -33.11% |
| 2020-06-30 | $-0.07B | $0.23B | -33.81% |
| 2020-03-31 | $-0.04B | $0.20B | -18.45% |
| 2019-12-31 | $0.02B | $0.23B | 8.12% |
| 2019-09-30 | $-0.02B | $0.19B | -10.31% |
| 2019-06-30 | $-0.01B | $0.19B | -6.76% |
| 2019-03-31 | $-0.01B | $0.19B | -6.58% |
| 2018-12-31 | $-0.01B | $0.17B | -8.32% |
| 2018-09-30 | $-0.01B | $0.16B | -9.56% |
| 2018-06-30 | $-0.01B | $0.15B | -4.36% |
| 2018-03-31 | $0.00B | $0.14B | -3.05% |
| 2017-12-31 | $0.00B | $0.14B | 0.00% |
| 2017-09-30 | $0.00B | $0.13B | -0.84% |
| 2017-06-30 | $0.00B | $0.12B | -0.88% |
| 2017-03-31 | $0.00B | $0.12B | 3.74% |
| 2016-12-31 | $0.00B | $0.11B | 4.00% |
| 2016-09-30 | $0.00B | $0.10B | 2.14% |
| 2016-06-30 | $0.00B | $0.10B | -1.13% |
| 2016-03-31 | $-0.04B | $0.09B | -41.06% |
| 2015-12-31 | $-0.04B | $0.09B | -62.98% |
| 2015-09-30 | $-0.04B | $0.08B | -120.30% |
| 2015-06-30 | $-0.04B | $0.08B | -318.37% |
| 2015-03-31 | $-0.01B | $-0.02B | 105.88% |
| 2014-12-31 | $-0.01B | $-0.02B | 282.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.665B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $187.241B | 82.01 |
| Thermo Fisher Scientific (TMO) | United States | $156.717B | 18.96 |
| Edwards Lifesciences (EW) | United States | $44.271B | 29.03 |
| Alcon (ALC) | Switzerland | $43.692B | 29.53 |
| IDEXX Laboratories (IDXX) | United States | $42.156B | 48.44 |
| DexCom (DXCM) | United States | $32.541B | 50.30 |
| IQVIA Holdings (IQV) | United States | $27.478B | 15.39 |
| Mettler-Toledo (MTD) | United States | $24.793B | 29.49 |
| STERIS (STE) | Ireland | $23.682B | 26.08 |
| Waters (WAT) | United States | $20.593B | 29.06 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.749B | 0.00 |
| Hologic (HOLX) | United States | $14.391B | 15.64 |
| Sysmex ADR (SSMXY) | Japan | $10.512B | 29.82 |
| Penumbra (PEN) | United States | $9.810B | 76.99 |
| Masimo (MASI) | United States | $9.055B | 33.40 |
| Globus Medical (GMED) | United States | $8.231B | 19.61 |
| Teleflex (TFX) | United States | $5.412B | 8.93 |
| TransMedics (TMDX) | United States | $4.833B | 105.06 |
| Integer Holdings (ITGR) | United States | $4.188B | 21.94 |
| PROCEPT BioRobotics (PRCT) | United States | $3.437B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.546B | 15.16 |
| Veracyte (VCYT) | United States | $2.187B | 30.69 |
| Nihon Kohden (NHNKY) | Japan | $2.115B | 24.25 |
| Elekta AB (EKTAY) | Sweden | $1.972B | 17.72 |
| Alphatec Holdings (ATEC) | United States | $1.715B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.435B | 0.00 |
| Artivion (AORT) | United States | $1.241B | 116.20 |
| Pulse Biosciences (PLSE) | United States | $1.125B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.997B | 5.30 |
| Beta Bionics (BBNX) | United States | $0.829B | 0.00 |
| SiBone (SIBN) | United States | $0.802B | 0.00 |
| IRadimed (IRMD) | United States | $0.763B | 38.72 |
| RxSight (RXST) | United States | $0.606B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.570B | 13.36 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.570B | 8.86 |
| Delcath Systems (DCTH) | United States | $0.556B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.537B | 0.00 |
| AxoGen (AXGN) | United States | $0.463B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.446B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.443B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.388B | 0.00 |
| NeuroPace (NPCE) | United States | $0.388B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.360B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.354B | 9.41 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| 908 Devices (MASS) | United States | $0.261B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.13 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.216B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.185B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.183B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.153B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.138B | 0.00 |
| Accuray (ARAY) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.084B | 51.00 |
| EnVVeno Medical (NVNO) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.22 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |